Wordt geladen...
Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine.
The Ebola virus is transmitted by direct contact with bodily fluids of infected individuals, eliciting death rates as high as 90% among infected humans. Currently, replication defective adenovirus-based Ebola vaccine is being studied in a phase I clinical trial. Another Ebola vaccine, based on an at...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Public Library of Science (PLoS)
2009-01-01
|
| Reeks: | PLoS ONE |
| Online toegang: | http://europepmc.org/articles/PMC2669164?pdf=render |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|